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ABSTRACT 
The Ireland-Claisen [3,3]-sigmatropic rearrangement has been used to access biologically important ’-dihydroxy 
-amino acids. The rearrangement reported is highly stereoselective and offers excellent levels of remote 
stereocontrol. This strategy has been used to synthesize the natural immunosuppressant mycestericin G and ent-
mycestericin G, allowing for a revision of absolute configuration of this natural product. 
The realization that naturally-occurring 
immunosuppressants, such as cyclosporin A,
1
 greatly 
reduce the likelihood of host rejection has made human 
organ transplantation a viable medical process.
2
 Arguably, 
this medical advance has profoundly changed society with 
heart, kidney, lung, liver and bone-marrow transplants 
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now routinely successful. A large range of natural 
products have now been demonstrated to possess 
immunosuppressive activity
3
 with recently reported 
examples seeking to improve biological activity or 
diminish side-effects. One of the most potent 
immunosuppressant natural products is myriocin, (1, 
Figure 1) which has been isolated from three different 
fungal sources.
4,5,6
 Impressively, myriocin displays a 10-
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100 fold increase in immunosuppressant potency 
compared with cyclosporin A.
6
  
 
 
Figure 1. Myriocin and ,'-Dihydroxy -Amino Acids 
 
Structure-activity studies have strongly suggested the 
crucial structural feature of 1 with respect to biological 
activity is the polar ’-dihydroxy -amino acid head 
group.
7
 Accordingly, flexible and efficient synthetic 
entries to such ’-dihydroxy -amino acids8 (2, Figure 
1) are potentially important for the discovery of new 
immunosuppressive treatments and related chemical 
biology studies.
9
 In addition, the structurally related 
natural products, sphingofungin E
10
 and mycestericins A-
G
11
, contain this key ,’-dihydroxy -amino acid 
moiety, and high levels of immunosuppressant activity 
have also been noted for both molecules.
12
 
In recent years we have been developing a programme 
of research directed toward the synthesis of novel amino 
acids through Ireland-Claisen rearrangements of 
substrates rich in heteroatom substitution.
13
 The Ireland-
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Claisen [3,3]-sigmatropic rearrangement is a key C-C 
bond forming reaction used in modern organic 
synthesis
14,15 
and is therefore ideally suited to such 
research effort. The rearrangement offers predictable 
diastereocontrol, chirality transfer and the ability to form 
congested quaternary stereocentres. These three key 
attributes stem from the preference of acyclic substrates to 
rearrange via a highly ordered chair transition state.  
Complex serine congeners, suitable for further 
elaboration to the natural product classes discussed above, 
might become accessible through sigmatropic 
rearrangements on serine-derived silylketene acetals. The 
employment of an Ireland-Claisen strategy for the 
synthesis of substituted serine analogues would require 
the generation of an unstable serine enolate. To avert this 
anticipated synthetic problem, the use of a serine-derived 
oxazolidine has been considered. Such a strategy would 
not only protect the sensitive -hydroxy by circumventing 
degradative E1Cb elimination
16
, it would also offer the 
potential to control absolute stereochemistry via the chiral 
relay strategy pioneered by Seebach.
17 
To examine this 
proposal, model ester substrate 3a was readily 
synthesized
18
 and subjected to standard Ireland-Claisen 
conditions used in our laboratory.
13 
 
Table 1. Ireland-Claisen Rearrangement of Oxazolidine Enol 
Ether Substrates. 
 
Entry 3 R 4 Yield (%) dra 
                                                                                      
75, 7491. (c) Tellam, J. P.; Carbery, D. R. Tetrahedron Lett.. 2011, 52, 
6027. (d) Ylioja, P. M.; Mosley, A. D.; Charlot, C. E.; Carbery, D. R. 
Tetrahedron Lett. 2008, 49, 1111. (e) Harker, W. R. R.; Carswell, E. L.; 
Carbery, D. R. Org. Lett. 2010 12, 3712. (f) Harker, W. R. R.; Carswell, 
E. L.; Carbery, D. R. Org. Biomol. Chem. 2012 
DOI:10.1039/C2OB06853B. 
(14) (a) Ireland, R. E.; Mueller, R. H.; J. Am. Chem. Soc. 1972, 94, 
5897. (b) Ireland, R. E.; Mueller, R. H.; Willard, A. K. J. Am. Chem. 
Soc. 1976, 98, 2868. (c) Ireland, R. E. Wipf, P. Armstrong III, J. D. J. 
Org. Chem. 1991, 56, 650. (d) Ireland, R. E. Wipf, P. Xiang, J. N. J. 
Org. Chem. 1991, 56, 3572. 
(15) For reviews concerning the Ireland-Claisen rearrangement, see: 
(a) Castro, A. M. Chem. Rev. 2004, 104, 2939. (b) Chai, Y. H.; Hong, 
S. P.; Lindsay, H. A.; McFarland, C.; McIntosh, M. C. Tetrahedron 
2002, 58, 2905. (c) McFarland, C. M.; McIntosh, M. C. The Claisen 
Rearrangement; Hiersemann, M. N., Nubbemeyer, U., Eds.; Wiley-
VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2007; p117. 
(d) Wipf, P. Claisen Rearrangements; Comprehensive Organic 
Synthesis; Trost, B. M., Fleming, I., Paquette, L. A., Eds.; Pergamon: 
Oxford, 1991; Vol 5, p827. (e) Ilardi, E. A.; Stivala, C. E.; Zakarian, A. 
Chem. Soc. Rev. 2009, 38, 3133. 
(16) For examples of Ireland-Claisen rearrangements in natural 
product synthesis using substrates bearing cyclic -ethereal oxygen 
centres, see: (a) Ireland, R. E.; Armstrong, J. D.; Lebreton, J.; Meissner, 
R. S.; Rizzacassa, M. A. J. Am. Chem. Soc. 1993, 115, 7152. (b) Bunte, 
J. O.; Cuzzupe, A. N.; Daly, A. M.; Rizzacasa, M. A. Angew. Chem. 
Int. Ed., 2006, 45, 6376. 
(17) (a) Seebach, D.; Aebi, J. D. Tetrahedron Lett. 1984, 25, 2545. 
(b) For a review of the self-regeneration chirality strategy, see: Seebach, 
D.; Sting, A. R.; Hoffmann, M. Angew. Chem. Int. Ed. 1996, 35, 2708. 
(18) See Supporting Information for details of substrate synthesis. 
1 3a Me 4a 78 >98:2 
2 3b Et 4b 84 >98:2 
3 3c iPr 4c 70 >98:2 
4 3d Allyl 4d 71 >98:2 
5 3e Propargyl 4e 76b >98:2 
6 3f Ph 4f 77 >98:2 
7 3g PMP 4g 68 >98:2 
8 3h p-CF3C6H4 4h 73 >98:2 
9 3i o-IC6H4 4i 58 >98:2 
10 3j Bn 4j 73 >98:2 
11 3k PMB 4k 75 >98:2 
12 3l o-I-Bn 4l 51d >98:2 
13 3m iBu 4m 55d >98:2 
14 3n Cy 4n 47d >98:2 
a Diastereomeric ratio stated as syn/anti. Measured by 1H NMR (500 
MHz) analysis of crude reaction mixture. b Isolated as TMS alkyne. c 
Reaction conducted on unpurified substrates 3l-n. 
 
On treatment with LiHMDS and Me3SiCl at -78 °C, the 
silylketene acetal derived from methyl enol ether 3a was 
found to rearrange smoothly, after warming to room 
temperature, with -methoxy product 4a isolated as a 
single stereoisomer in 78% yield (Table 1, entry 1). The 
stereoselectivity is notable, not only for its magnitude, but 
also because the controlling stereocentre is two atoms 
from the forming C-C bond. This stereocontrol strategy 
has previously shown limited efficacy in asymmetric 
synthesis.
14,19
 
The Ireland-Claisen rearrangement reaction of enol 
ethers 3a-n is general and leads to the formation of -
alkoxy and -aryloxy -amino acid products, isolated as 
methyl esters 4a-n in good yield and excellent 
diastereoselectivity. The absolute and relative 
stereochemistry has been confirmed by XRD of iodoaryl 
ether 4i (Figure 2). 
 
 
 
Figure 2. ORTEP Plot of XRD analysis of 4i (at 30% 
probability). Structure deposited with CCDC (CCDC 812147) 
and proposed Ireland-Claisen rearrangement geometry I. 
 
The observed sense of stereoselectivity is consistent 
with transition state geometry I (Figure 2) whereby the 
enol ether fragment approaches the silylketene acetal anti 
to the oxazolidine tert-butyl group and agrees with 
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reported stereoselective transformations using this 
regeneration of stereocentres tactic.
20
 Notably, the 
rearrangement of substrates bearing O-functional handles 
(entries 4-5, 9, 13) and O-protecting groups (entries 4, 7, 
10, 12) suggest that this strategy may be of future 
synthetic value. This sigmatropic transformation is highly 
stereoselective in each case. In three instances, however, 
the substrate proved to be particularly unstable, 
necessitating it being used without purification for 
conversion to the rearranged allylic ether products in 
yields of 47-55% over two steps (entries 13-15). It is 
unclear exactly why these substrates have proven to be so 
sensitive, however, we can speculate that the substantial 
steric cost of these alkyl groups (o-iodobenzyl, 
i
butyl and 
cyclohexyl) promotes a conformational restriction of the 
enol ether oxygen, improving On donation into the enol 
ether -system, ultimately leading to increased sensitivity. 
However, it was found that these systems rearrange as 
efficiently as that seen in entries 1-12 (70-80%), when the 
yield of ester formation is taken into account.
 
The Ireland-
Claisen rearrangement products 4a-n are equivalent to O-
alkyl and O-aryl aldols and, when placed in this context, 
the power of this rearrangement becomes apparent. Low 
levels of diastereoselectivity (dr ≤ 2:1) are observed when 
serine-derived oxazolidine esters are used in aldol 
reactions in conjunction with simple achiral aldehydes.
21 
The rearrangement is amenable to streamlined 
preparative scale (4 mmol of 6) manipulations. For 
example, when EDCI mediated coupling of 5
22
 and 6,
12a
 
Ireland-Claisen rearrangement and carboxyl benzylation 
are conducted without intermediate purification, ent-4k is 
isolated in 81% over three steps (Scheme 2). 
 
Scheme 1. Preparative Scale Rearrangement. 
 
 
This rearrangement reaction offers a rapid access to 
complex and functionalized ’-dihydroxy -amino 
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acids motifs. To demonstrate the synthetic potential, a 
synthesis of mycestericin G (8, Scheme 2) has been 
examined. This natural product features a polyhydroxy -
amino acid head group and lipophilic tail, offering a 
potential entry from the cross-metathesis union of a 
rearrangement product 7 and a suitable lipophilic olefin 
partner, such as 9 (Scheme 2). Our envisioned strategy 
was to examine olefin homodimer 9
23
 in combination with 
the 2
nd
 generation Hoveyda-Grubbs Ru-carbene catalyst
24
 
as Grubbs has previously demonstrated the improved 
performance of homodimers
25
 and the stated catalyst in 
sterically congested allylic alcohols
26
 in cross-metathesis 
reactions. 
 
Scheme 2. Mycestericin G Synthetic Strategy 
 
 
The synthesis of mycestericin G was completed after 
PMB deprotection of 7, cross metathesis and 
hydrogenation, with final N-Boc oxazolidine cleavage 
furnishing mycestericin G after chromatography. The 
1
H 
NMR data was in excellent agreement with that reported, 
but the optical rotation was opposite in sign, yet of a 
similar magnitude to that quoted (Scheme 3). In contrast, 
the parallel synthetic sequence from L-serine produced 
ent-8, now with the same sense of optical rotation and 
comparable magnitude to that reported for mycestericin 
G. 
 
Scheme 3. Total Synthesis of Mycestericin G 
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To explain this discrepency, we offer the following 
analysis. Hydrogenation of 1 forms dihydromyriocin 10 
(Scheme 3).
27
 Key is the realisation that hydrogenation of 
the seemingly innocuous olefin in 1 leads to a reversal in 
the sense of optical rotation i.e. myriocin 1 is 
dextrorotatory whilst 10 is levorotatory. 
 
 
Figure 3. Effect of alkene on sense of optical rotation. 
 
The absolute configuration of mycesterin E (11) has 
been determined through the total synthesis.
28
 This report 
also demonstrated that mycestericin G (8) was obtained 
from synthetic 11, forming material which was observed 
to have identical spectroscopic data. However, no optical 
rotation data was reported for this synthetic mycestericin 
G. Therefore, there is not an unequivocal demonstration 
that the configuration of the stereocenters in mycestericin 
E is the same as the two stereocenters in mycestricin G. 
The recent elegant synthesis of mycestericin G by 
Kumagai and Shibasaki is of particular interest.
12i
 This 
effort resulted in the synthesis of the structure originally 
reported; however, with an opposite sense of optical 
rotation to that in the original isolation paper. We feel that 
this observation offers further credence to a reassignment 
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of configuration of the natural immunosupressant 
mycestericin G. 
In conclusion, an Ireland-Claisen route to 
polyhydroxyamino acids, using a self-regeneration of 
stereocenters strategy, has been developed. It has also 
been applied in a succinct synthesis of mycestericin G and 
ent-mycestericin G, allowing a reassignment of 
configuration of this immunosuppressant natural product. 
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